When the phenotypic consequences of siRNA-mediated ZRF1 depletion were analyzed, no differences were found in cell proliferation (Figure 6b), wound healing (Figure 6c), invasion through collagen (Figure 6d), or resistance to neuroblastoma therapies such as chemotherapeutics or RA (Figure 6e). The gene discussed is DNAJC2; the disease is neuroblastoma.